ARTICLE | Clinical News
Sarawak began U.S. Phase Ib testing of (+)-calanolide A
October 5, 1998 7:00 AM UTC
Sarawak MediChem Pharmaceuticals Inc., Lemont, Ill. Product: (+)-calanolide A non-nucleoside reverse transcriptase inhibitor (NNRTI) Indication: Treat HIV infection/AIDS Status: Sarawak began U.S. Pha...